The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...
Early detection and modern treatments make cervical cancer one of the most preventable and treatable cancers. Newport Women’s ...
A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...
During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by technological ...
Chemotherapy significantly improves overall and cancer-specific survival in cervical cancer patients undergoing radiotherapy, especially in those aged 65 to 80 years. The benefits of chemotherapy ...
SAN FRANCISCO -- Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with ...
Standard chemoradiation outperforms de-intensified treatments in HPV-associated oropharyngeal cancer
Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III ...
BARCELONA – Adding preoperative chemoradiation to standard-of-care perioperative chemotherapy did not improve overall or progression-free survival in patients with resectable adenocarcinoma of the ...
Patients with unresectable stage 3 non-small cell lung cancer treated with Tecentriq before and following chemoradiation may derive a survival benefit. Tecentriq (atezolizumab) administered before and ...
According to preliminary data from a multi-institution Phase III trial intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when ...
An early-phase, dose-escalation study of a hypofractionated approach to concurrent chemoradiation using an an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results